A G E N D A 1. APOLOGIES FOR ABSENCE Ian Metcalfe 2 ...

Quality Impact Assessments 2013/14The above process has been implemented for all transformation programmes (corporate and clinicalschemes) identified for 2013/14.All individual schemes have been quality impact assessed at directorate meetings. Support for the QIAprocess has been provided to directorates by the Transformation Programme Manager and AssociateDirector Clinical Governance.The QIA template has ensured that each scheme identifies the following: Directorate Project reference Scheme title Area of quality (Patient experience, patient outcome, safety) Quality impact (Improve, Maintain or Reduce quality) Risk rating (Improve = Green, Maintain = Amber, Reduce = Red) Data Source (Drop down menu provided linked to primary quality metrics to included on thenew Board and Directorate quality dashboards)AIRsSUIHSMRFriends and Family TestDelayed Transfer of CareReadmissionsMRSACDiffRTTLength of StayRegulatory ComplianceComplaintsSickness AbsenceStaffingAppraisalsMandatory TrainingMonitoring Forum (i.e. where the above metrics will be routinely discussed in addition to thedirectorate management & clinical governance forums)The three year plans incorporated a total of 145 individual clinical work streams, and include theRBCH 13/14 schemes. These work streams were impact assessed by the directorates andsubsequently reviewed by the Medical Director and Director of Nursing. Of the 145 work streamsreviewed, 11 were not approved and further information and assessment has been requested.